BOULDER, Colo., Jun 20, 2012 (BUSINESS WIRE) -- The Shuman Law Firm today announced that it is investigating potential claims against certain officers and directors of directors of DaVita, Inc. ("DaVita" or the "Company") /quotes/zigman/268700/quotes/nls/dva DVA +0.27% . DaVita provides kidney dialysis and administrative services, including related laboratory services for medical facilities across the United States. DaVita's dialysis and related laboratory services business accounts for approximately 93% of the Company's consolidated net operating revenues.

DaVita is the subject of two qui tam lawsuits which allege that DaVita executives have, for many years, systemically overprescribed patients their medications related to kidney dialysis in order to receive the maximum reimbursement from the federal government. These actions have purportedly cost taxpayers millions of dollars in illegal and unjustified payments to DaVita. DaVita is also currently being investigated by multiple U.S. Attorneys, the U.S. Department of Justice and the U.S. Department of Health and Human Services regarding these claims.

If you currently own DaVita common stock and are interested in discussing your rights as a shareholder, or have information relating to this investigation, please contact Kip B. Shuman or Rusty E. Glenn toll-free at (866) 974-8626 or email Mr. Shuman at This e-mail address is being protected from spambots. You need JavaScript enabled to view it or email Mr. Glenn at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

The Shuman Law Firm represents investors throughout the nation, concentrating its practice in securities class actions and shareholder derivative actions.

SOURCE: The Shuman Law Firm

        
        The Shuman Law Firm 
        Kip B. Shuman, Esq., 866-974-8626 
        
 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
  
        or 
        Rusty E. Glenn, Esq., 866-974-8626 
        
 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
  
 
www.shumanlawfirm.com            

Copyright Business Wire 2012

...